MedPath

Volume status by bioimpedance spectroscopy assessment in hypertensive chronic kidney disease patients

Not Applicable
Conditions
Chronic kidney disease patient stage 3&#45
5 who never recieved renal replacement therapy and diagnosed hypertension
Chronic kidney disease Hypertension Bioimpedance spectroscopy volume overload central blood pressure pulse wave velocity
Registration Number
TCTR20170329001
Lead Sponsor
Division of Nephrology, Depatment of medicine, Faculty of Medicine, Chulalongkorn University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Enrolling by invitation
Sex
All
Target Recruitment
46
Inclusion Criteria

Chronic kidney disease patient stage 3-5 who never recieved renal replacement therapy and diagnosed hypertension
Age 18-80 years old
Regulra follow up at King Chulalongkorn memorial hospital at least 1 year

Exclusion Criteria

Congestive heart failure
clinical edema
Chronic kidney disease with secondary hypertension
Patient on pacemaker or defibrillation implant
Pregnancy Implantation of artificial joints or pins amputee
BMI>40kg/m2
Bedridden
Patient with serious life limiting comorbid situation เช่น end stage malignancy, uncontrolled infection, active inflammation, end stage heart disease

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Prevalence of overhydration in chronic kidney disease stage 3-5 with hypertension May 16 - April 17 Body Composition Monitor (BCM) device
Secondary Outcome Measures
NameTimeMethod
The relationship of cardiovascular risk factor and overhydration state May 16 - April 17 clinical parameters from patient's record
© Copyright 2025. All Rights Reserved by MedPath